×
About 3,530 results

ALLMedicine™ Hyperbilirubinemia Center

Research & Reviews  1,205 results

Positive direct antiglobulin test: is it a risk factor for significant hyperbilirubinem...
https://doi.org/10.1055/a-1709-5036
American Journal of Perinatology; Ercin S, Coskun Y et. al.

Dec 1st, 2021 - ABO incompatibility is a common cause of neonatal indirect hyperbilirubinemia. The direct antiglobulin test (DAT) can identify infants developing hemolytic disease. This study aims to evaluate the significance of DAT positivity among neonates with...

Maternal exposure to air pollution may increase the risk of hyperbilirubinemia in her n...
https://doi.org/10.1016/j.jpeds.2021.11.057
The Journal of Pediatrics; Nelin T, Burris HH

Nov 29th, 2021 - Maternal exposure to air pollution may increase the risk of hyperbilirubinemia in her newborn.|2021|Nelin T,Burris HH,|

Transient congenital hyperinsulinism and hemolytic disease of a newborn despite rhesus ...
https://doi.org/10.1186/s13256-021-03167-9 10.1016/j.jpeds.2015.03.057 10.1159/000335333 10.1159/000446396 10.1016/j.ejmg.2019.02.004 10.1111/j.1537-2995.2008.01742.x 10.1111/j.1440-1754.2010.01874.x 10.1016/j.jpeds.2015.02.045 10.1210/jc.2008-0510 10.1186/s40246-015-0029-z
Journal of Medical Case Reports; Riis SST, Joergensen MH et. al.

Nov 29th, 2021 - In neonates, rhesus D alloimmunization despite anti-D immunoglobulin prophylaxis is rare and often unexplained. Rhesus D alloimmunization can lead to hemolytic disease of the newborn with anemia and unconjugated hyperbilirubinemia. In past reports...

Cystic artery pseudoaneurysm-a rare complication of acute cholecystitis: review of lite...
https://doi.org/10.1007/s00464-021-08796-1
Surgical Endoscopy; Patil NS, Kumar AH et. al.

Nov 24th, 2021 - To acquaint with the presentation and management of the cystic artery aneurysm by enriching the reviewed literature with our own experience. Cystic artery pseudoaneurysm is an uncommon entity with varied clinical presentation. Inflammation and tra...

Effectiveness of Dual-Blanket Phototherapy Compared With Combination Phototherapy on Ra...
https://doi.org/10.1016/j.pedhc.2021.10.002
Journal of Pediatric Health Care : Official Publication O... Wiegert S, Mai H

Nov 21st, 2021 - The purpose of this study was to evaluate the effectiveness of dual light-emitting diode (LED) blanket phototherapy compared with combination LED phototherapy on the rate of total serum bilirubin (TSB) decline and treatment duration among full-ter...

see more →

Guidelines  3 results

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for UGT1A1 and Ata...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4785051
Clinical Pharmacology and Therapeutics; Gammal RS, Court MH et. al.

Sep 30th, 2015 - The antiretroviral protease inhibitor atazanavir inhibits hepatic uridine diphosphate glucuronosyltransferase (UGT) 1A1, thereby preventing the glucuronidation and elimination of bilirubin. Resultant indirect hyperbilirubinemia with jaundice can c...

Phototherapy to prevent severe neonatal hyperbilirubinemia in the newborn infant 35 or ...
https://doi.org/10.1542/peds.2011-1494
Pediatrics Bhutani VK, et. al.

Sep 29th, 2011 - To standardize the use of phototherapy consistent with the American Academy of Pediatrics clinical practice guideline for the management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Relevant literature was reviewed. P...

Universal screening for hyperbilirubinemia.
https://doi.org/10.1111/j.1751-486X.2010.01516.x
Nursing for Women's Health;

Feb 9th, 2010 - Universal screening for hyperbilirubinemia.|2010||blood,blood,diagnosis,standards,

see more →

Drugs  32 results see all →

Clinicaltrials.gov  57 results

Assessment of Neonatal Hyperbilirubinemia by NeoprediX B.1 Algorithm
https://clinicaltrials.gov/ct2/show/NCT05121311

Nov 16th, 2021 - Neonatal jaundice is common and mostly transient without need for intervention. To identify infants at risk of bilirubin toxicity, bilirubin is measured several times after birth and before discharge home. As the peak bilirubin concentrations are ...

Multi-center Clinical Study on Neonatal Hyperbilirubinemia
https://clinicaltrials.gov/ct2/show/NCT03824990

Nov 1st, 2021 - Through a prospective cohort study of healthy term and near-term infants, the study tries to truly reflect the epidemiology, intervention status, and outcomes of neonatal hyperbilirubinemia and the cost. Hopefully, by improving the quality of mana...

Tactile and Kinaesthetic Stimulation in Neonates With Hyperbilirubinaemia
https://clinicaltrials.gov/ct2/show/NCT05077787

Oct 14th, 2021 - Hyperbilirubinemia is the commonest problem seen in neonates, owing to severe complications in lifetime. The study design of the study is pretest - posttest experimental design. Convenience Sampling will be used for recruiting the neonates. In stu...

Medical Optimization of Management of Type 2 Diabetes Complicating Pregnancy (MOMPOD)
https://clinicaltrials.gov/ct2/show/NCT02932475

Sep 13th, 2021 - Purpose: The objective of this proposal is to study the safety and efficacy of metformin added to insulin for treatment of type 2 diabetes mellitus (T2DM) among pregnant women. Participants: 950 pregnant women with type 2 diabetes complicating pre...

Major Surgery as a Risk of Gall Stone Disease?
https://clinicaltrials.gov/ct2/show/NCT04675190

Sep 1st, 2021 - The risk factors for the development of gall stones are multiple which a reason for its high prevalence. Past history of major surgeries does carry some of the biological causations of the gall stones like prolonged fasting during the perioperativ...

see more →

News  113 results

Chemotherapy With FOLFOX Superior to TACE in Liver Cancer
https://www.medscape.com/viewarticle/962798

Nov 11th, 2021 - Hepatic arterial infusion chemotherapy (HAIC) with FOLFOX led to superior patient outcomes and less toxicity than standard of care transarterial chemoembolization (TACE) for patients with large, unresectable hepatocellular carcinoma (HCC), a rando...

Chemotherapy with FOLFOX superior to TACE in liver cancer
https://www.mdedge.com/hematology-oncology/article/248519/gastrointestinal-cancer/chemotherapy-folfox-superior-tace-liver
Pam Harrison

Nov 10th, 2021 - Hepatic arterial infusion chemotherapy (HAIC) with FOLFOX led to superior patient outcomes and less toxicity than standard of care transarterial chemoembolization (TACE) for patients with large, unresectable hepatocellular carcinoma (HCC), a rando.

Expert Recaps Advances in AML
https://www.onclive.com/view/expert-recaps-advances-in-aml

Oct 6th, 2021 - Rami S. Komrokji, MD Now that physicians have access to novel therapies for patients with acute myeloid leukemia (AML) following a 30-year gap in therapeutic development, physicians must now aim to understand their optimal placement in treatment,...

Global Real-World Data Establish TheraSphere Y-90 as Optimal Choice for HCC
https://www.onclive.com/view/global-real-world-data-establish-therasphere-y-90-as-optimal-choice-for-hcc

Oct 6th, 2021 - TheraSphere Y-90 glass microspheres offer a precision medicine technique aimed at delivering high-dose radiation directly to tumors. Most recently, investigators examined data from the retrospective TARGET study (NCT03295006), which aimed to provi...

Personalized Radioembolization Improves OS Vs Standard Dosing in Advanced HCC
https://www.onclive.com/view/personalized-radioembolization-improves-os-vs-standard-dosing-in-advanced-hcc

Oct 6th, 2021 - Yttrium-90 (Y-90) glass microspheres (TheraSphere) administered in a personalized, dosimetric approach demonstrated a 16-month improvement in overall survival (OS) compared with a standard dosimetric approach in patients with unresectable hepatoce...

see more →

Patient Education  2 results see all →